North America Biohacking Market Size & Outlook, 2024-2030
North America biohacking market, 2018-2030 (US$M)
Related Markets
North America biohacking market highlights
- The North America biohacking market generated a revenue of USD 9,111.2 million in 2024.
- The market is expected to grow at a CAGR of 18.6% from 2025 to 2030.
- In terms of segment, wearables was the largest revenue generating product in 2024.
- Smart Drugs is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2025 to 2030.
North America data book summary
| Market revenue in 2024 | USD 9,111.2 million |
| Market revenue in 2030 | USD 25,046.0 million |
| Growth rate | 18.6% (CAGR from 2025 to 2030) |
| Largest segment | Wearables |
| Fastest growing segment | Smart Drugs |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Wearables, Implants (Chips), Gene Modification Kits, Smart Drugs, Supplements, Mobile Apps |
| Key market players worldwide | Apple Inc, Fitbit, Harvey Norman Holdings Ltd, The ODIN, Thync, Moodmetric, Thriveport, TrackMyStack, OsteoStrong San Jose |
Other key industry trends
- In terms of revenue, North America region accounted for 36.7% of the global biohacking market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 17,205.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biohacking Market Scope
Biohacking Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America biohacking market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biohacking market will help companies and investors design strategic landscapes.
Wearables was the largest segment with a revenue share of 35% in 2024. Horizon Databook has segmented the North America biohacking market based on wearables, implants (chips), gene modification kits, smart drugs, supplements, mobile apps covering the revenue growth of each sub-segment from 2018 to 2030.
North America biohacking market dominated in 2024 and accounted for the market share of 36.73%. The biohacking market in North America is driven by strong investments in biotechnology, a growing consumer base for personalized health solutions, and the presence of leading biohacking companies.
Advancements in wearable biosensors, neurotechnology, and genetic engineering tools such as CRISPR are fueling market growth. The increasing adoption of biohacking practices in wellness, anti-aging, and cognitive enhancement is further propelling demand. Additionally, support from venture capital firms and innovation hubs in Silicon Valley and beyond is fostering the rapid commercialization of biohacking technologies.
Reasons to subscribe to North America biohacking market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America biohacking market databook
-
Our clientele includes a mix of biohacking market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America biohacking market , including forecasts for subscribers. This continent databook contains high-level insights into North America biohacking market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America biohacking market size, by country, 2018-2030 (US$M)
North America Biohacking Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
